Navigation Links
Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
Date:3/25/2008

HOPKINTON, Mass., March 25 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that the Company will host a conference call on Tuesday, April 1st, 2008 at 10:00am EDT to review 2007 Financial Results and discuss other matters related to the Company.

To access the conference call, please dial 877-718-5104 for domestic and 719-325-4843 international. The code for this conference call is 7767549. Please dial in 5 to 10 minutes prior to the scheduled start time. A replay of the call will be posted on the Investor Relations section of the website, http://www.alseres.com, within 48 hours following the conference call and will be available through Tuesday, April 15th, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. Cethrin(R), a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including b
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
2. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
3. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
4. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
5. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
6. XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
7. SGX Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
8. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
9. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
10. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
11. Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)... N.J., May 12 /- Forest,Lab...ceutical company, and,Daiichi Sankyo, Inc. today a...ion agreement for AZOR(TM)* (amlodipine and olmesa...nation of two antihypertensives, the,calcium chann... receptor,blocker olmesartan medoxomil. Forest wil...
(Date:5/12/2008)...swire-FirstCall/ -- Vical Incorporated (Nasdaq:,VI...ef Executive Officer,Vijay B. Samant, will provid...opment programs, and strategic partnerships at thr...America 2008 Health Care Conference (Las Vegas, Ma...Spring Investor Conference (New York, May 28-...
(Date:5/12/2008)...ewswire/ - Cytochroma today announced that it,has ...cial Officer (CFO).,Mr. Wieland, 63, brings to Cyt...nd financial management, at both public and privat...inois office., "Rich has strong leadership skills...s and significant expertise in the capital markets...
(Date:5/11/2008)...ood Riots. (Atlantic and Latin America,editions). ...ort on the,world food crisis with a primer on the ...s spiral out of control, the worry is that million... its ravages. Over the past few,months, there have...ces,have risen farther and faster than agricultura...
Breaking Biology Technology:Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 2Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 3Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement 4Vical to Present at Upcoming Investor Conferences 2Cytochroma Appoints R. Richard Wieland II As CFO 2Newsweek International Editions: Highlights And Exclusives, May 19, 2008 2Newsweek International Editions: Highlights And Exclusives, May 19, 2008 3Newsweek International Editions: Highlights And Exclusives, May 19, 2008 4Newsweek International Editions: Highlights And Exclusives, May 19, 2008 5
...ists love to compare the performance of Minnesota ...states, all removed from the East and West coasts,... ,But the comparisons end when it comes to federal...ries. There, Wisconsin is a dismal third, and it h...tate is failing to keep up with the Joneses. , ,Wh...
...avel got turned on its head again last week, as Br...sives aboard U.S.-bound aircraft. For the vast maj...e checked baggage, if only to be assured they have...destinations (Im envisioning a new business opport...rminals). For the sake of security, well all wait ...
...n, Wis. - The economic feasibility of crushing se...ll be the subject of an investigation funded by $6...Secretary Rod Nilsestuen handed an agricultural bu...ct that could unlock the energy in soybean, sunflo...tate. , ,O,Brien Farms, in collaboration with Gre...
...dison, Wis. - Last week, the nation marked the f... restrictions on stem cell research. Those restric... this promising research, scientists and experts s...d have lifted President Bush,s restrictions, there...are suffering from a wide range of debilitating di...
Other Biology Technology:Wisconsin's failure to attract federal defense dollars crimps tech economy 2Wisconsin's failure to attract federal defense dollars crimps tech economy 3Opportunities rise from travel chaos 2Stem cell research holds the promise for tomorrow 2Stem cell research holds the promise for tomorrow 3
(Date:5/9/2008)...on of compound found to induce neurotransmitter ac...searchers to develop potential novel therapies to ...erosis, Huntingtons disease, epilepsy, stroke/isch..., Va. (May 9, 2008) Virginia Commonwealth Univers...works to modulate the activity of a neurotransmitt...
(Date:5/9/2008)...14 produced by above-ground nuclear testing in the...hat the number of fat cells in a human,s body, whe...age years. Changes in fat mass in adulthood can be...not an increase in the actual number of fat cells....new pharmaceuticals to battle obesity as well as t...
(Date:5/9/2008)...apped their comfortable offices for one of the mos... out a challenging field campaign that is seen as ...e mission CryoSat will be as accurate as possible....any and Canada, are currently in the middle of Cry...nsive three-week experiment programme in the far n...
(Date:5/8/2008)...(DNA) of humans and many other organisms have been... to discovering how the many thousands of structur...cells that can turn genes on and off -- function. ...s and tools. Scientists in the Optical Microscopy ...ry at Florida State University, working in collabo...
Breaking Biology News(10 mins):Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 3New technique determines the number of fat cells remains constant in all body types 2New technique determines the number of fat cells remains constant in all body types 3Scientists endure Arctic for last campaign prior to CryoSat-2 launch 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 3Magnet Lab researchers make observing cell functions easier 2inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc 13643 1inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc 13643 2inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc 13643 3Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 1Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 2Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 3Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 4Hill Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill Rom Products Using Nanotechnology 13638 5New guidelines update recommendations on colorectal cancer screening 13635 1New guidelines update recommendations on colorectal cancer screening 13635 2New guidelines update recommendations on colorectal cancer screening 13635 3New guidelines update recommendations on colorectal cancer screening 13635 4PharmAthene Completes Pharmacokinetic Studies of Protexia 28R 29 3B Program on Target for IND Filing in 2008 3756 1PharmAthene Completes Pharmacokinetic Studies of Protexia 28R 29 3B Program on Target for IND Filing in 2008 3756 2PharmAthene Completes Pharmacokinetic Studies of Protexia 28R 29 3B Program on Target for IND Filing in 2008 3756 3PharmAthene Completes Pharmacokinetic Studies of Protexia 28R 29 3B Program on Target for IND Filing in 2008 3756 4
...s of an elusive drug target on the outer wall of b...ormation to aid design of novel antibiotics. The d...itiated by Staphylococcus aureus and other bacteri...Strynadka, a Howard Hughes Medical Institute (HHMI... of British Columbia in Vancouver, Canada, publish...
...ls will travel across a colony to actively seek ma...ather than mate with local dominant males. These ... that female choice may be more widespread in natu...es enable species to maintain genetic diversity. ,...he British Antarctic Survey (BAS) studied a colony...
...can complicate treatment after many surgical proce...lococcus aureus (MRSA), which has been found in ma...ative complication. In a study published in the Ap..., researchers found MRSA infections in the eyes of... the first cases of MRSA infectious keratitis foll...
...tend to weigh less than children who sleep less, a... be overweight five years later. That’s one of the...nuary/February 2007 issue of the journal Child Dev...rn University, the study looked at 2,281 children ... Child Development Supplement of the Panel Survey ...
Other Biology News:Bacterial walls come tumbling down 2Bacterial walls come tumbling down 3Female Antarctic seals give cold shoulder to local males 2Drug-resistant bacterial infections serious complication after corrective eye surgery 2Children who sleep more weigh less 2
I-Ab MHC Class II
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case
BD BioCoat Collagen I 60 mm Culture Dishes BD BioCoat Collagen I 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of rat tail collagen type I. Coating : Collage
BssH II Bacillus stearothermophilus from Sigma-Aldrich
Biology Products: